India Still Viable for Drug Innovation, Hisey Says

India Still Viable for Drug Innovation, Hisey Says Play

April 1 (Bloomberg) -- Terry Hisey, vice chairman and U.S. life sciences leader at Deloitte LLP, talks about a ruling by India's Supreme Court denying Novartis AG's request for patent protection for its Gleevec cancer treatment. He speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

  • On Air Now

    Charlie Rose Watch Now

  • Next

    Taking Stock with Pimm Fox

blog comments powered by Disqus